20 Feb 2020 --- Tapping into the skin-gut axis, UK-based AxisBiotix, a subsidiary of SkinBioTherapeutics, has made an agreement with Dutch company Winclove Probiotics to develop and manufacture a probiotic food supplement to help manage symptoms of mild-medium psoriasis. The companies will design and develop good bacterial strains based on the modifying properties of specific bacterial species on known psoriasis disease pathways. The move indicates a larger trend of looking to the microbiome for a range of ailments from cognition to skincare.
